(Updated - November 21, 2017 7:06 AM EST)

BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.

Earnings Guidance